| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA541308
Max Phase: Preclinical
Molecular Formula: C19H21BrClNS
Molecular Weight: 374.35
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CSc1ccc(C2CN3CCCC3c3c(Br)cccc32)cc1.Cl
Standard InChI: InChI=1S/C19H20BrNS.ClH/c1-22-14-9-7-13(8-10-14)16-12-21-11-3-6-18(21)19-15(16)4-2-5-17(19)20;/h2,4-5,7-10,16,18H,3,6,11-12H2,1H3;1H
Standard InChI Key: NUULVIXSLQBEMD-UHFFFAOYSA-N
Associated Targets(non-human)
Dopamine transporter 139 Activities
Norepinephrine transporter 42 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Serotonin transporter 150 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus 284745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 374.35 | Molecular Weight (Monoisotopic): 373.0500 | AlogP: 5.45 | #Rotatable Bonds: 2 |
| Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 9.08 | CX LogP: 5.32 | CX LogD: 3.63 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.64 | Np Likeness Score: -0.40 |
References
| 1. Maryanoff BE, Vaught JL, Shank RP, McComsey DF, Costanzo MJ, Nortey SO.. (1990) Pyrroloisoquinoline antidepressants. 3. A focus on serotonin., 33 (10): [PMID:2213832] [10.1021/jm00172a018] |
Source
Source(1):